本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Soligenix, Inc.

2.06
+0.06003.00%
盤後2.00-0.0600-2.91%19:57 EDT
成交量:11.20萬
成交額:22.92萬
市值:650.05萬
市盈率:-0.41
高:2.11
開:2.08
低:1.96
收:2.00
資料載入中...

公司資料

公司名字:
Soligenix, Inc.
交易所:
NASDAQ
成立時間:
1987
員工人數:
15
公司地址:
29 Emmons Drive,Suite B-10,Princeton,New Jersey,United States
郵編:
08540
電話:
傳真:
609 452 6467
簡介:
Soligenix, Inc.成立於1987年,是一家臨床階段生物製藥公司,專註於開發產品,治療癌症和嚴重的胃腸道疾病的治療所產生的危及生命的副作用(仍然是一個未滿足的醫療需求),以及開發多種生物防禦疫苗和療法。

董事

名稱
職位
Christopher J. Schaber
Chairman of the Board, Chief Executive Officer and President
Diane L. Parks
Director
Gregg A. Lapointe
Director
Jerome B. Zeldis
Director
Robert J. Rubin
Director

股東

名稱
職位
Christopher J. Schaber
Chairman of the Board, Chief Executive Officer and President
Jonathan Guarino
Chief Financial Officer, Senior Vice President and Corporate Secretary
Oreola Donini
Chief Scientific Officer and Senior Vice President
Richard Straube
Chief Medical Officer and Senior Vice President